Well-established GBM-specific molecular features were identified across all samples, including frequent mutations in EGFR, TP53, and PTEN genes; copy number gains of EGFR; and copy number loss of PTEN, CDKN2A, CDKN2B, and MTAP [3, 4, 24]. This evidence concerns the gene PTEN and glioblastoma.